Table 9.
Summary of individual study findings for women with breast cancer-related lymphedema symptom duration <12 months
| Citation | Excess arm volume | HRQOL | Heaviness | Arm function | Patient benefit | Group difference p |
| Complex decongestive treatment (CDT/DLT) | ||||||
| Dayes et al. 201335,aDLT groupbControl groupb | YY | OO | OO | >.05 | ||
| Gradalski et al. 201582CDT groupcCB group | Y‡ | Y‡ | Y‡ | >.05‡ | ||
| Haghighat et al. 201375,aCDT groupb | Y | Not reported | Not applicable | |||
| Hwang et al. 201379CDT group 1 (<20% ELV)cCDT group 2 (≥20% ELV) | O‡ | Not applicable | ||||
| Compression bandaging (CB) and manual lymph drainage (MLD) | ||||||
| McNeely et al. 200436,CB+MLD groupbCB groupb | YY | Not reported | ||||
| Complex decongestive physiotherapy (CDPT) and active resistive exercise (ARE) | ||||||
| Kim et al. 201080CDPT+ARE groupcCDPT groupc | YY | >.05 | ||||
| Low level laser therapy | ||||||
| Kaviani et al. 200681Laser groupcSham groupc | ?? | ?? | Not reported | |||
Y = improved; O = unchanged; N = worse; ? = data unclear.
aData provided by corresponding author.
bSubgroup of women with BCRL duration <12months.
cMean breast cancer-related lymphedema duration ≤9 months.
‡ = data not presented: mean BCRL duration >9 months.